Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
The ‘secretly awesome’ side of a teaching career
The freedom to do “wacky” research projects that interest you is a major perk of the teaching stream, says Suzanne Wood, a teaching professor at the University of Toronto.
The ‘secretly awesome’ side of a teaching career
The freedom to do “wacky” research projects that interest you is a major perk of the teaching stream, says Suzanne Wood, a teaching professor at the University of Toronto.
Manifestantes argentinos denuncian el recorte al financiamiento científico
Manifestantes alrededor del país exigieron al gobierno que aumente los salarios de las universidades públicas y el financiamiento para la investigación científica.
Manifestantes argentinos denuncian el recorte al financiamiento científico
Manifestantes alrededor del país exigieron al gobierno que aumente los salarios de las universidades públicas y el financiamiento para la investigación científica.
Outside influences on CHD8 variant phenotypes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 18 May.
Outside influences on CHD8 variant phenotypes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 18 May.